Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 143

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Molecular and cellular regulation of human glucokinase

Sternisha, Shawn M., Miller, Brian G. · 2019 · Archives of Biochemistry and Biophysics

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.abb.2019.01.011

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 141

  1. Wilson, 1995, Hexokinases, Rev. Physiol. Biochem. Pharmacol., 126, 65, 10.1007/BFb0049776 · DOI · Paper page
  2. Ferre, 1996, Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver, FASEB J., 10, 1213, 10.1096/fasebj.10.10.8751724 · DOI · Paper page
  3. Printz, 1993, Mammalian glucokinase, Annu. Rev. Nutr., 10.1146/annurev.nu.13.070193.002335 · DOI · Paper page
  4. Iynedjian, 1993, Mammalian glucokinase and its gene, Biochem. J., 293, 1, 10.1042/bj2930001 · DOI · Paper page
  5. Matschinsky, 1990, Glucokinase as glucose sensor and metabolic signal generator in pancreatic β-cells and hepatocytes, Diabetes, 39, 647, 10.2337/diab.39.6.647 · DOI · Paper page
  6. Kawai, 2005, Structures, evolution, and ancestor of glucose kinases in the hexokinase family, J. Biosci. Bioeng., 10.1263/jbb.99.320 · DOI
  7. Cárdenas, 1998, Evolution and regulatory role of the hexokinases, Biochim. Biophys. Acta Mol. Cell Res., 1401, 242, 10.1016/S0167-4889(97)00150-X · DOI · Paper page
  8. Aiston, 1999, Glucose-6-phosphatase overexpression lowers glucose 6-phosphate and inhibits glycogen synthesis and glycolysis in hepatocytes without affecting glucokinase translocation. Evidence against feedback inhibition of glucokinase, J. Biol. Chem., 10.1074/jbc.274.35.24559 · DOI
  9. Osbak, 2009, Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia, Hum. Mutat., 30, 1512, 10.1002/humu.21110 · DOI · Paper page
  10. Kim, 2015, Maturity-onset diabetes of the young: what do clinicians need to know?, Diabetes Metab. J., 39, 468, 10.4093/dmj.2015.39.6.468 · DOI
  11. Matschinsky, 2011, Glucokinase activators for diabetes therapy: may 2010 status report, Diabetes Care, 10.2337/dc11-s236 · DOI
  12. Bowler, 2013, Small-molecule allosteric activation of human glucokinase in the absence of glucose, ACS Med. Chem. Lett., 10.1021/ml400061x · doi:10.1021/ml400061x
  13. Grewal, 2014, Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus, Mini Rev. Med. Chem., 10.2174/1389557514666140722082713 · doi:10.2174/1389557514666140722082713
  14. Xiao, 2013, Enantioselective synthesis of tatanans A-C and reinvestigation of their glucokinase-activating properties, Nat. Chem., 10.1038/nchem.1597 · doi:10.1038/nchem.1597
  15. Shelton, 1992, Multiple elements in the upstream glucokinase promoter contribute to transcription in insulinoma cells, Mol. Cell Biol.
  16. Jetton, 1994, Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut, J. Biol. Chem., 269, 3641, 10.1016/S0021-9258(17)41910-7 · DOI · Paper page
  17. Moates, 2004, The Pal elements in the upstream glucokinase promoter exhibit dyad symmetry and display cell-specific enhancer activity when multimerised, Diabetologia, 10.1007/s00125-004-1497-1 · DOI
  18. Moates, 2003, BETA2 activates transcription from the upstream glucokinase gene promoter in islet β-cells and gut endocrine cells, Diabetes, 10.2337/diabetes.52.2.403 · DOI
  19. Iynedjian, 1988, Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats, J. Biol. Chem., 263, 740, 10.1016/S0021-9258(19)35415-8 · DOI · Paper page
  20. Wu, 2004, A potential role for fructose-2,6-bisphosphate in the stimulation of hepatic glucokinase gene expression, Endocrinology, 10.1210/en.2003-1290 · DOI
  21. Roth, 2004, The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway, J. Biol. Chem., 10.1074/jbc.M308391200 · DOI
  22. Iynedjian, 1995, Glucokinase and cytosolic phosphoenolpyruvate carboxykinase (GTP) in the human liver. Regulation of gene expression in cultured hepatocytes, J. Clin. Invest., 95, 10.1172/JCI117880 · DOI
  23. Agius, 2016, Hormonal and metabolite regulation of hepatic glucokinase, Annu. Rev. Nutr., 36, 389, 10.1146/annurev-nutr-071715-051145 · DOI
  24. Kamata, 2004, Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase, Structure, 12, 429, 10.1016/j.str.2004.02.005 · DOI · Paper page
  25. Nishimura, 2009, Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators, Bioorg. Med. Chem. Lett, 19, 1357, 10.1016/j.bmcl.2009.01.053 · DOI · Paper page
  26. Pal, 2009, Activating mutations in the human glucokinase gene revealed by genetic selection, Biochemistry, 48, 814, 10.1021/bi802142q · doi:10.1021/bi802142q
  27. Liu, 2012, Insights into mechanism of glucokinase activation: observation of multiple distinct protein conformations, J. Biol. Chem.
  28. Richard, 1974, Regulatory behavior of monomeric enzymes: 1. The mnemonical enzyme concept, Eur. J. Biochem., 10.1111/j.1432-1033.1974.tb03825.x · doi:10.1111/j.1432-1033.1974.tb03825.x
  29. Ainslie, 1972, Transients and cooperativity. A slow transition model for relating transients and cooperative kinetics of enzymes, J. Biol. Chem., 247, 7088, 10.1016/S0021-9258(19)44697-8 · DOI · Paper page
  30. Neet, 1990, Observation of a kinetic slow transition in monomeric glucokinase, Biochemistry, 10.1021/bi00455a026 · doi:10.1021/bi00455a026
  31. Heredia, 2006, Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations, J. Biol. Chem., 281, 40201, 10.1074/jbc.M607987200 · DOI
  32. Antoine, 2009, Binding kinetics of glucose and allosteric activators to human glucokinase reveal multiple conformational states, Biochemistry, 10.1021/bi900374c · DOI
  33. Whittington, 2015, Dual allosteric activation mechanisms in monomeric human glucokinase, Proc. Natl. Acad. Sci. U.S.A., 112, 11553, 10.1073/pnas.1506664112 · DOI · Paper page
  34. Larion, 2012, Order-disorder transitions govern kinetic cooperativity and allostery of monomeric human glucokinase, PLoS Biol., 10, 10.1371/journal.pbio.1001452 · DOI · Paper page
  35. Sternisha, 2018, Mechanistic origins of enzyme activation in human glucokinase variants associated with congenital hyperinsulinism, Biochemistry, 10.1021/acs.biochem.8b00022 · DOI · Paper page
  36. Bowler, 2013, Small-molecule allosteric activation of human glucokinase in the absence of glucose, ACS Med. Chem. Lett., 4, 580, 10.1021/ml400061x · doi:10.1021/ml400061x
  37. Van Schaftingen, 1989, A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6‐phosphate and fructose 1‐phosphate, Eur. J. Biochem., 179, 179, 10.1111/j.1432-1033.1989.tb14538.x · DOI · Paper page
  38. Van Schaftingen, 1992, The regulatory protein of liver glucokinase, Adv. Enzym. Regul., 32, 133, 10.1016/0065-2571(92)90013-P · DOI
  39. Choi, 2013, Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase, Proc. Natl. Acad. Sci. U.S.A., 110, 10171, 10.1073/pnas.1300457110 · DOI
  40. Beck, 2013, Structural basis for regulation of human glucokinase by glucokinase regulatory protein, Biochemistry, 52, 6232, 10.1021/bi400838t · DOI
  41. Lenzen, 2014, A fresh view of glycolysis and glucokinase regulation: history and current status, J. Biol. Chem., 289, 12189, 10.1074/jbc.R114.557314 · DOI · Paper page
  42. Shiota, 1999, Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase, J. Biol. Chem., 274, 37125, 10.1074/jbc.274.52.37125 · DOI
  43. Agius, 2008, Glucokinase and molecular aspects of liver glycogen metabolism, Biochem. J., 414, 1, 10.1042/BJ20080595 · DOI · Paper page
  44. Arden, 2006, Glucokinase regulatory protein is associated with mitochondria in hepatocytes, FEBS Lett., 580, 2065, 10.1016/j.febslet.2006.03.009 · DOI
  45. Johansson, 2017, Nuclear import of glucokinase in pancreatic beta-cells is mediated by a nuclear localization signal and modulated by SUMOylation, Mol. Cell. Endocrinol., 454, 146, 10.1016/j.mce.2017.06.020 · DOI
  46. Anderka, 2008, Biophysical characterization of the interaction between hepatic glucokinase and its regulatory protein: impact of physiological and pharmacological effectors, J. Biol. Chem., 283, 31333, 10.1074/jbc.M805434200 · DOI
  47. Pautsch, 2013, Supporting Information Crystal structure of glucokinase regulatory protein, Biochemistry, 52, 1, 10.1021/bi4000782 · DOI
  48. Lloyd, 2013, Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors, Nature, 504, 437, 10.1038/nature12724 · DOI
  49. Casey, 2016, Kinetic basis of carbohydrate-mediated inhibition of human glucokinase by the glucokinase regulatory protein, Biochemistry, 10.1021/acs.biochem.6b00349 · doi:10.1021/acs.biochem.6b00349
  50. Martinez, 2017, Antidiabetic disruptors of the glucokinase-glucokinase regulatory protein complex reorganize a coulombic interface, Biochemistry, 10.1021/acs.biochem.7b00377 · DOI
  51. Park, 2015, Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity, Sci. Rep., 5, 1, 10.1038/srep17395 · DOI
  52. Watanabe, 2018, Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein, Nat. Commun., 9, 1, 10.1038/s41467-017-02537-6 · DOI
  53. Veiga-Da-Cunha, 2009, Evolution of vertebrate glucokinase regulatory protein from a bacterial N-acetylmuramate 6-phosphate etherase, Biochem. J., 423, 323, 10.1042/BJ20090986 · DOI
  54. Orho-Melander, 2008, Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations, Stroke, 57, 3112
  55. Sparsø, 2008, The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes, Diabetologia, 51, 70, 10.1007/s00125-007-0865-z · DOI · Paper page
  56. Baltrusch, 2001, Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library: identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner, J. Biol. Chem., 276, 43915, 10.1074/jbc.M105470200 · DOI
  57. Smith, 2007, Molecular coordination of hepatic glucose metabolism by the 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase:glucokinase complex, Mol. Endocrinol., 21, 1478, 10.1210/me.2006-0356 · doi:10.1210/me.2006-0356
  58. Baltrusch, 2012, Additive activation of glucokinase by the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and the chemical activator LY2121260, Biochem. Pharmacol., 83, 1300, 10.1016/j.bcp.2012.01.020 · doi:10.1016/j.bcp.2012.01.020
  59. Massa, 2004, Interaction of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) with glucokinase activates glucose phosphorylation and glucose metabolism in insulin-producing cells, Diabetes, 53, 1020, 10.2337/diabetes.53.4.1020 · DOI
  60. Cullen, 2011, Susceptibility of glucokinase-MODY mutants to inactivation by oxidative stress in pancreatic β-cells, Diabetes, 10.2337/db11-0423 · DOI
  61. Tiedge, 2000, Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase, Arch. Biochem. Biophys., 375, 251, 10.1006/abbi.1999.1666 · DOI
  62. Baltrusch, 2007, Novel insights into the regulation of the bound and diffusible glucokinase in MIN6 β-cells, Diabetes, 56, 1305, 10.2337/db06-0894 · DOI
  63. Payne, 2007, Contributions of glucokinase and phosphofructokinase-2/fructose bisphosphatase-2 to the elevated glycolysis in hepatocytes from Zucker fa/fa rats, Am. J. Physiol. Regul. Integr. Comp. Physiol., 293, R618, 10.1152/ajpregu.00061.2007 · DOI
  64. Cullen, 2014, Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein, Biochim. Biophys. Acta Mol. Cell Res., 1843, 1123, 10.1016/j.bbamcr.2014.02.006 · DOI
  65. Langer, 2010, Endogenous activation of glucokinase by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is glucose dependent, Mol. Endocrinol., 24, 10.1210/me.2010-0115 · doi:10.1210/me.2010-0115
  66. Mukhtar, 2008, Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, AJP Regul. Integr. Comp. Physiol., 10.1152/ajpregu.00593.2007 · DOI
  67. Payne, 2005, Dual role of phosphofructokinase-2/fructose bisphosphatase-2 in regulating the compartmentation and expression of glucokinase in hepatocytes, Diabetes, 54, 1949, 10.2337/diabetes.54.7.1949 · DOI
  68. Watanabe, 2010, Quantitative image analysis reveals that phosphorylation of liver-type isozyme of fructose-6-phosphate 2-kinase/fructose-2,6-bisphosphatase does not affect nuclear translocation of glucokinase in rat primary hepatocytes, J. Biochem., 148, 713, 10.1093/jb/mvq107 · DOI
  69. Yang, 2010, Molecular modeling of BAD complex resided in a mitochondrion integrating glycolysis and apoptosis, J. Theor. Biol., 266, 231, 10.1016/j.jtbi.2010.06.009 · DOI
  70. Danial, 2009, Bad: undertaker by night, candyman by day, Oncogene, 27
  71. Szlyk, 2014, A phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activators, Nat. Struct. Mol. Biol., 21, 36, 10.1038/nsmb.2717 · DOI
  72. Lee, 2009, Mitochondrial dysfunction: glucokinase downregulation lowers interaction of glucokinase with mitochondria, resulting in apoptosis of pancreatic β-cells, Cell. Signal., 21, 69, 10.1016/j.cellsig.2008.09.015 · DOI
  73. Giménez-Cassina, 2014, Regulation of hepatic energy metabolism and gluconeogenesis by BAD, Cell Metabol., 19, 272, 10.1016/j.cmet.2013.12.001 · DOI
  74. Rexford, 2017, Biochemical and biophysical investigations of the interaction between human glucokinase and pro-apoptotic BAD, PLoS One, 12, 10.1371/journal.pone.0171587 · DOI
  75. Zhang, 2002, Development of a high-throughput fluorescence polarization assay for Bcl-xL, Anal. Biochem., 307, 70, 10.1016/S0003-2697(02)00028-3 · DOI
  76. Yu, 2004, JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD, Mol. Cell., 13, 329, 10.1016/S1097-2765(04)00028-0 · DOI · Paper page
  77. Grimsby, 2000, Characterization of glucokinase regulatory protein-deficient mice, J. Biol. Chem., 275, 7826, 10.1074/jbc.275.11.7826 · DOI
  78. Bjørkhaug, 2007, Allosteric activation of human glucokinase by free polyubiquitin chains and its ubiquitin-dependent cotranslational proteasomal degradation, J. Biol. Chem., 282, 22757, 10.1074/jbc.M700517200 · DOI
  79. Yan, 2005, Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels, Am. J. Physiol. Cell Physiol., 289, C1351, 10.1152/ajpcell.00240.2005 · DOI
  80. Kitiphongspattana, 2005, Proteasome inhibition alters glucose-stimulated (pro)insulin secretion and turnover in pancreatic β-cells, J. Biol. Chem., 280, 15727, 10.1074/jbc.M410876200 · DOI
  81. Kawaguchi, 2006, Essential role of ubiquitin-proteasome system in normal regulation of insulin secretion, J. Biol. Chem., 281, 13015, 10.1074/jbc.M601228200 · DOI
  82. López-Avalos, 2006, Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets, Diabetes, 55, 1223, 10.2337/db05-0450 · DOI
  83. Callis, 2014, The ubiquitination machinery of the ubiquitin system, Arab. B., 12, e0174, 10.1199/tab.0174 · DOI · Paper page
  84. Hofmeister-Brix, 2013, Identification of the ubiquitin-like domain of midnolin as a new glucokinase interaction partner, J. Biol. Chem., 288, 35824, 10.1074/jbc.M113.526632 · DOI
  85. Grabbe, 2009, Functional roles of ubiquitin-like domain (ULD) and ubiquitin-binding domain (UBD) containing proteins, Chem. Rev., 10.1021/cr800413p · DOI
  86. Walters, 2004, Ubiquitin family proteins and their relationship to the proteasome: a structural perspective, Biochim. Biophys. Acta Mol. Cell Res., 10.1016/j.bbamcr.2004.10.005 · DOI
  87. Nandi, 2006, The ubiquitin-proteasome system, J. Biosci., 31, 137, 10.1007/BF02705243 · DOI · Paper page
  88. Ravid, 2008, Diversity of degradation signals in the ubiquitin-proteasome system, Nat. Rev. Mol. Cell Biol., 9, 679, 10.1038/nrm2468 · DOI · Paper page
  89. Kravtsova-Ivantsiv, 2012, Non-canonical ubiquitin-based signals for proteasomal degradation, J. Cell Sci., 125, 539, 10.1242/jcs.093567 · DOI · Paper page
  90. Muratani, 2003, How the ubiquitin-proteasome system controls transcription, Nat. Rev. Mol. Cell Biol., 4, 192, 10.1038/nrm1049 · DOI · Paper page
  91. Hofmeister-Brix, 2013, The ubiquitin-proteasome system regulates the stability and activity of the glucose sensor glucokinase in pancreatic β-cells, Biochem. J., 456, 173, 10.1042/BJ20130262 · DOI
  92. Flotho, 2013, Sumoylation: a regulatory protein modification in health and disease, Annu. Rev. Biochem., 82, 357, 10.1146/annurev-biochem-061909-093311 · DOI · Paper page
  93. Bologna, 2013, It takes two to tango: ubiquitin and SUMO in the DNA damage response, Front. Genet., 4, 10.3389/fgene.2013.00106 · DOI
  94. Jackson, 2013, Regulation of DNA damage responses by ubiquitin and SUMO, Mol. Cell., 49, 795, 10.1016/j.molcel.2013.01.017 · DOI · Paper page
  95. Johnson, 2004, Protein modification by SUMO, Annu. Rev. Biochem., 73, 355, 10.1146/annurev.biochem.73.011303.074118 · DOI · Paper page
  96. Gareau, 2010, The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition, Nat. Rev. Mol. Cell Biol., 11, 861, 10.1038/nrm3011 · DOI · Paper page
  97. Geiss-friedlander, 2007, Concepts in sumoylation: a decade on, Nat. Rev. Mol. Cell Biol., 8, 947, 10.1038/nrm2293 · DOI · Paper page
  98. Miura, 2007, Sumoylation, a post-translational regulatory process in plants, Curr. Opin. Plant Biol., 10, 495, 10.1016/j.pbi.2007.07.002 · DOI · Paper page
  99. Wilkinson, 2012, Mechanisms, regulation and consequences of protein SUMOylation, Biochem. J., 428, 133, 10.1042/BJ20100158 · DOI · Paper page
  100. Kanakousaki, 2012, A differential requirement for SUMOylation in proliferating and non-proliferating cells during Drosophila development, Development, 139, 2751, 10.1242/dev.082974 · doi:10.1242/dev.082974
  101. Bawa-Khalfe, 2010, SUMO losing balance: SUMO proteases disrupt SUMO homeostasis to facilitate cancer development and progression, Genes Canc., 1, 748, 10.1177/1947601910382555 · DOI
  102. Wang, 2004, SUMO-1 modification activated GATA4-dependent cardiogenic gene activity, J. Biol. Chem., 279, 49091, 10.1074/jbc.M407494200 · DOI
  103. Aukrust, 2013, SUMOylation of pancreatic glucokinase regulates its cellular stability and activity, J. Biol. Chem., 288, 5951, 10.1074/jbc.M112.393769 · DOI
  104. Galán, 2006, Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability, Biochem. J., 393, 389, 10.1042/BJ20051137 · DOI
  105. V Burke, 1999, Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI), Biochem. J., 342, 345, 10.1042/bj3420345 · DOI
  106. Grimsby, 2003, Allosteric activators of glucokinase: potential role in diabetes therapy, Science, 301, 370, 10.1126/science.1084073 · DOI · Paper page
  107. Caron, 2013, Annexin A1 is regulated by domains cross-talk through post-translational phosphorylation and SUMOYlation, Cell. Signal, 25, 1962, 10.1016/j.cellsig.2013.05.028 · DOI
  108. Jongjitwimol, 2016, Sumoylation of eIF4A2 affects stress granule formation, J. Cell Sci., 129, 2407, 10.1242/jcs.184614 · DOI
  109. Ulrich, 2005, SUMO modification: wrestling with protein conformation, Curr. Biol., 15, 10.1016/j.cub.2005.03.021 · doi:10.1016/j.cub.2005.03.021
  110. a Campbell, 2008, Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1), Mol. Cell Biol., 28, 7476, 10.1128/MCB.00103-08 · DOI
  111. Dai, 2011, SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans, Diabetes, 60, 838, 10.2337/db10-0440 · DOI · Paper page
  112. Toyoda, 1997, Glucokinase is located in secretory granules of pancreatic D-cells, FEBS Lett., 415, 281, 10.1016/S0014-5793(97)01139-3 · DOI
  113. Toyoda, 1999, Glucokinase is concentrated in insulin-secretory granules of pancreatic B-cells, Histochem, Cell Biol., 112, 35
  114. Stubbs, 2000, Subcellular localization, mobility, and kinetic activity of glucokinase in glucose-responsive insulin-secreting cells, Diabetes, 49, 2048, 10.2337/diabetes.49.12.2048 · DOI
  115. Markwardt, 2012, Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels, Mol. Endocrinol., 26, 1617, 10.1210/me.2012-1183 · DOI
  116. Rizzo, 2002, A functional link between glucokinase binding to insulin granules and conformational alterations in response to glucose and insulin, J. Biol. Chem., 277, 34168, 10.1074/jbc.M112478200 · DOI
  117. Rizzo, 2003, Regulation of β cell glucokinase by S-nitrosylation and association with nitric oxide synthase, J. Cell Biol., 161, 243, 10.1083/jcb.200301063 · DOI
  118. Arden, 2004, Glucokinase is an integral component of the insulin granules in glucose-responsive insulin secretory cells and does not translocate during glucose stimulation, Diabetes, 53, 2346, 10.2337/diabetes.53.9.2346 · DOI
  119. Ding, 2010, Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation, Mol. Endocrinol., 24, 171, 10.1210/me.2009-0138 · DOI
  120. Tiedge, 2000, Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase, Arch. Biochem. Biophys., 10.1006/abbi.1999.1666 · DOI
  121. Markwardt, 2016, Regulation of glucokinase by intracellular calcium levels in pancreatic β cells, J. Biol. Chem., 10.1074/jbc.M115.692160 · DOI
  122. Ding, 2011, Glucagon-like peptide 1 stimulates post-translational activation of glucokinase in pancreatic β cells, J. Biol. Chem., 10.1074/jbc.M110.192799 · DOI
  123. Weir, 1989, Glucagonlike peptide I (7-37) actions on endocrine pancreas, Diabetes, 10.2337/diab.38.3.338 · DOI · Paper page
  124. Seckinger, 2018, Nitric oxide activates β-cell glucokinase by promoting formation of the “glucose-Activated” state, Biochemistry, 57, 5136, 10.1021/acs.biochem.8b00333 · DOI
  125. Murata, 1997, Co-localization of glucokinase with actin filaments, FEBS Lett., 406, 109, 10.1016/S0014-5793(97)00253-6 · DOI
  126. Magnuson, 1992, Tissue-specific regulation of glucokinase gene expression, J. Cell. Biochem., 48, 115, 10.1002/jcb.240480202 · DOI
  127. Balasubramanian, 2007, A role for F-actin in hexokinase-mediated glucose signaling, Plant Physiol., 145, 1423, 10.1104/pp.107.108704 · DOI
  128. Balasubramanian, 2008, Actin-based cellular framework for glucose signaling by Arabidopsis hexokinase1, Plant Signal. Behav., 3, 322, 10.4161/psb.3.5.5319 · DOI
  129. Wagner, 1999, Viscoelastic properties of f-actin, microtubules, f-actin/α-actinin, and f-actin/Hexokinase determined in microliter volumes with a novel nondestructive method, biophys, J, 76, 2784
  130. Fields, 1989, A novel genetic system to detect protein-protein interactions. [Yeast two hybrid], Nature, 340, 245, 10.1038/340245a0 · DOI · Paper page
  131. Fields, 1994, The two-hybrid system: an assay for protein-protein interactions, Trends Genet., 10, 286, 10.1016/0168-9525(90)90012-U · DOI · Paper page
  132. Stynen, 2012, Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system, Microbiol. Mol. Biol. Rev., 76, 331, 10.1128/MMBR.05021-11 · DOI · Paper page
  133. Muñoz-Alonso, 2000, A novel cytosolic dual specificity phosphatase, interacting with glucokinase, increases glucose phosphorylation rate, J. Biol. Chem., 275, 32406, 10.1074/jbc.M000841200 · DOI
  134. Renatus, 2012, Phosphorylation meets proteolysis, Structure, 20, 570, 10.1016/j.str.2012.03.006 · doi:10.1016/j.str.2012.03.006
  135. Shiraishi, 2001, A novel glucokinase regulator in pancreatic β cells. Precursor of propionyl-CoA carboxylase β subunit interacts with glucokinase and augments its activity, J. Biol. Chem., 276, 2325, 10.1074/jbc.C000530200 · DOI
  136. V Bhagavan, 2013, Essentials of medical biochemistry with clinical cases, Essentials Med. Biochem., 151
  137. Baltrusch, 2006, Glucokinase regulatory network in pancreatic β-cells and liver, Diabetes, 10.2337/db06-S008 · DOI
  138. Schmitt, 2017, Spatial organization of metabolic enzyme complexes in cells, Biochemistry, 10.1021/acs.biochem.7b00249 · DOI
  139. Kohnhorst, 2017, Identification of a multienzyme complex for glucose metabolism in living cells, J. Biol. Chem., 10.1074/jbc.M117.783050 · DOI
  140. Baltrusch, 2006, Improved metabolic stimulus for glucose-induced insulin secretion through GK and PFK-2/FBPase-2 coexpression in insulin-producing RINm5F cells, Endocrinology, 147, 5768, 10.1210/en.2006-0694 · DOI
  141. Arden, 2008, A role for PFK-2/FBPase-2, as distinct from fructose 2,6-bisphosphate, in regulation of insulin secretion in pancreatic beta-cells, Biochem. J., 411, 41, 10.1042/BJ20070962 · DOI

Cited by

See all 143

Metadata

Authors
Sternisha, S. M., & Miller, B. G.
Venue
Archives of Biochemistry and Biophysics
Publisher
Elsevier BV
Published
2019-03
Volume
663
Pages
199-213
ISSN
0003-9861
Cited by
143
References
9
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
NIH (GM115388)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular and cellular regulation of human glucokinase. https://app.cochat.ai/papers/10.1016/j.abb.2019.01.011
The paper
Sternisha, S. M., & Miller, B. G. (2019). Molecular and cellular regulation of human glucokinase. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2019.01.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.